Gb-115

GB-115, also known by the chemical name N-(6-phenylhexanoyl)-glycyl-L-tryptophan amide or the brand name Ranquilon, is a synthetic dipeptide that has recently gained approval in Russia. It's a derivative of cholecystokinin tetrapeptide (CCK-4) and is being researched for its effects on stress and cognitive function.

How It Works

Think of your brain as having a complex communication system, and some of these communication channels are influenced by a neuropeptide called cholecystokinin (CCK). When CCK gets too active, especially in areas of the brain linked to emotions and stress, it can contribute to feelings of anxiety and panic.

GB-115 works primarily by acting as a selective antagonist for central cholecystokinin (CCK-1 and CCK-2) receptors. Essentially, it blocks these receptors, preventing CCK from binding and over-exciting those anxiety-related brain circuits. This helps to dampen stress-induced emotional responses without causing the sedation or motor impairment often seen with other anxiety medications. It also seems to modulate neuropeptidergic tone, which can prevent acute spikes in stress hormones like cortisol. Unlike some traditional anxiety medications, it doesn't directly interact with GABA-A receptors.

Typical Dosing

In clinical studies for Generalized Anxiety Disorder (GAD), an effective dose of GB-115 was determined to be 6 mg per day. This was often administered in tablet form. Some research suggests that while there might be a mild acute effect, the full anxiolytic benefits often become more noticeable after several days to a week, and sometimes up to a month, with consistent use.

It's important to note that oral bioavailability for GB-115 can be low, around 4.65%, which is why other formulations like intranasal sprays are being explored to improve absorption.

Benefits

Research suggests GB-115 offers several potential benefits, particularly for those dealing with anxiety and related issues:

Anxiety Reduction: It has shown significant anxiolytic (anxiety-reducing) effects, with studies indicating a substantial reduction in anxiety scores in patients with Generalized Anxiety Disorder (GAD).

Fatigue Reduction: Clinical trials have also shown significant reductions in fatigue.

Cognitive Enhancement: GB-115 may improve cognitive functions such as attention, information processing, and reaction speed. These cognitive benefits appear to build over time.

Stress Response Modulation: It helps neutralize emotional stress responses and can prevent the acute elevation of cortisol and other stress biomarkers.

Improved Sleep: Studies suggest a beneficial effect on sleep disturbances.

Non-Sedating with Stimulating Properties: Unlike many anxiolytics, GB-115 is described as having mild psychostimulant properties and does not typically induce sedation, muscle relaxation, or motor impairment. It also doesn't seem to cause the initial overactivation, anxiety, or sleep disturbances sometimes seen with first-line GAD treatments like SSRIs and SNRIs.

Anti-inflammatory Effects: Preclinical studies have shown anti-inflammatory effects, suppressing the generation of active oxygen forms by neutrophils.

Risks & Considerations

While studies suggest GB-115 is generally safe and well-tolerated, it's crucial to remember a few things:

Limited Human Data: While clinical trials have been conducted, much of the detailed research is still emerging, and long-term human safety data is not as extensive as for established medications.

Bioavailability: Its low oral bioavailability means that the dosage and delivery method can significantly impact its effectiveness.

Individual Response: As with any compound, individual responses can vary. Some people report immediate effects, while others find it takes longer to notice benefits.

Potential for Interactions: While it doesn't act on GABA-A receptors like benzodiazepines, its interaction with other medications is still something to consider and discuss with a healthcare provider.

Who It's For

GB-115 appears to be particularly promising for individuals experiencing:

Generalized Anxiety Disorder (GAD): Clinical trials have focused heavily on its efficacy in reducing anxiety symptoms in GAD patients.

Stress-Related Fatigue and Cognitive Impairment: Its ability to reduce fatigue and enhance attention and processing speed makes it potentially useful for those whose stress manifests with mental exhaustion and difficulty concentrating.

Those Seeking Non-Sedating Anxiolytics: If you're looking for anxiety support that doesn't cause drowsiness or impair motor skills, GB-115's profile might be of interest.

It's probably not for you if you're looking for a quick, "euphoric" fix, as it's described as taking the edge off without inducing euphoria.

This is for educational purposes only — always work with a licensed provider before starting any protocol.